Sign Up to like & get
recommendations!
2
Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.advprecmed20-09
Abstract: Introduction: The neurotrophic tyrosine receptor kinase (NTRK) genes NTRK1, 2, and 3 have emerged as oncogenic drivers, and their resultant tropomyosin receptor kinase (TRK) proteins are targets for precision medicines. Larotrectinib, a selective TRK inhibitor,…
read more here.
Keywords:
gene fusions;
fusion;
pts trk;
ntrk gene ... See more keywords